Pflug Koory’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-75
Closed -$16K 471
2021
Q4
$16K Hold
75
0.01% 333
2021
Q3
$14K Sell
75
-450
-86% -$88.6K 0.01% 338
2021
Q2
$94K Buy
525
+250
+91% +$47.6K 0.05% 211
2021
Q1
$46K Sell
275
-250
-48% -$41.7K 0.03% 256
2020
Q4
$80K Sell
525
-100
-16% -$13.1K 0.05% 216
2020
Q3
$63K Hold
625
0.04% 216
2020
Q2
$76K Hold
625
0.06% 202
2020
Q1
$59K Sell
625
-50
-7% -$4.75K 0.05% 202
2019
Q4
$59K Hold
675
0.04% 223
2019
Q3
$54K Sell
675
-125
-16% -$10.1K 0.04% 222
2019
Q2
$62K Hold
800
0.05% 210
2019
Q1
$94K Sell
800
-75
-9% -$8.74K 0.07% 189
2018
Q4
$95K Hold
875
0.08% 168
2018
Q3
$112K Sell
875
-400
-31% -$49.5K 0.09% 170
2018
Q2
$144K Buy
1,275
+400
+46% +$44K 0.11% 152
2018
Q1
$98K Hold
875
0.08% 174
2017
Q4
$129K Sell
875
-150
-15% -$19.1K 0.1% 165
2017
Q3
$120K Hold
1,025
0.1% 164
2017
Q2
$133K Hold
1,025
0.11% 161
2017
Q1
$139K Hold
1,025
0.12% 154
2016
Q4
$147K Buy
+1,025
New +$131K 0.13% 148

Other funds holding UTHR

Pflug Koory's UTHR Position: Q1 2022 in Review

Pflug Koory sold out of United Therapeutics (UTHR) in Q1 2022, closing a stake of 75 shares — an estimated $16K sold.

Pflug Koory first reported a position in UTHR in Q4 2016 and held it in 21 quarters. The position peaked at $147K in Q4 2016. 428 funds tracked by Wall St. Rank hold UTHR as of Q1 2022.

  • Pflug Koory reported no remaining United Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Pflug Koory sold 75 United Therapeutics shares in Q1 2022, an estimated $16K.
  • Pflug Koory first reported a position in United Therapeutics in Q4 2016 and held it in 21 quarters.
  • Pflug Koory's United Therapeutics position peaked at $147K in Q4 2016.
  • 428 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2022.

Based on Pflug Koory's 13F filing for Q1 2022, filed 14 Apr 2022.